These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 20949807)

  • 1. Botulinum toxin type A for the treatment of urinary tract dysfunction in neurological disorders.
    O'Leary M; Dierich M
    Urol Nurs; 2010; 30(4):228-34. PubMed ID: 20949807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study of botulinum toxin A in neurogenic bladder due to spina bifida in children.
    Deshpande AV; Sampang R; Smith GH
    ANZ J Surg; 2010 Apr; 80(4):250-3. PubMed ID: 20575951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of botulinum toxin type a in the bladder wall of children with neurogenic bladder dysfunction: a comparison of histological features before and after injections.
    Pascali MP; Mosiello G; Boldrini R; Salsano ML; Castelli E; De Gennaro M
    J Urol; 2011 Jun; 185(6 Suppl):2552-7. PubMed ID: 21527192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of urinary tract infection after detrusor botulinum toxin A injections for refractory neurogenic detrusor overactivity in patients with no antibiotic treatment.
    Harris MA; Harding C; Fulford S; Whiteway J
    BJU Int; 2011 Apr; 107(7):1165; author reply 1165. PubMed ID: 21438980
    [No Abstract]   [Full Text] [Related]  

  • 5. Risk of urinary tract infection after detrusor botulinum toxin A injections for refractory neurogenic detrusor overactivity in patients with no antibiotic treatment.
    Mouttalib S; Khan S; Castel-Lacanal E; Guillotreau J; De Boissezon X; Malavaud B; Marque P; Rischmann P; Gamé X
    BJU Int; 2010 Dec; 106(11):1677-80. PubMed ID: 20590550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electromotive drug administration of lidocaine to anesthetize the bladder before botulinum-A toxin injections into the detrusor.
    Schurch B; Reitz A; Tenti G
    Spinal Cord; 2004 Jun; 42(6):338-41. PubMed ID: 15007374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A simplified technique for botulinum toxin injections in children with neurogenic bladder.
    Pascali MP; Mosiello G; Marciano A; Capitanucci ML; Zaccara AM; De Gennaro M
    J Urol; 2011 Jun; 185(6 Suppl):2558-62. PubMed ID: 21527204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Botulinum toxin for chronic migraine.
    Med Lett Drugs Ther; 2011 Jan; 53(1356):7-8. PubMed ID: 21252842
    [No Abstract]   [Full Text] [Related]  

  • 9. Adverse events after botulinum A toxin injection for neurogenic voiding disorders.
    De Laet K; Wyndaele JJ
    Spinal Cord; 2005 Jul; 43(7):397-9. PubMed ID: 15741978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum toxin: a new dimension in the treatment of lower urinary tract dysfunction.
    Rajkumar GN; Conn IG
    Urology; 2004 Jul; 64(1):2-8. PubMed ID: 15245922
    [No Abstract]   [Full Text] [Related]  

  • 11. Onabotulinum toxin A for the treatment of neurogenic detrusor overactivity due to spinal cord injury or multiple sclerosis.
    Goessaert AS; Everaert KC
    Expert Rev Neurother; 2012 Jul; 12(7):763-75. PubMed ID: 22853784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Editorial comment on: botulinum toxin A improves the quality of life of patients with neurogenic urinary incontinence.
    Kocjancic E
    Eur Urol; 2007 Sep; 52(3):858-9. PubMed ID: 17467880
    [No Abstract]   [Full Text] [Related]  

  • 13. Injection of botulinum toxin type A in the urethral sphincter to treat lower urinary tract dysfunction: review of indications, techniques and results: 2011 update.
    Mahfouz W; Karsenty G; Corcos J
    Can J Urol; 2011 Aug; 18(4):5787-95. PubMed ID: 21854710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How to save botulinum toxin A in the treatment of focal axillary hyperhidrosis.
    Bechara FG; Sand M; Hoffmann K
    Dermatology; 2006; 213(4):356. PubMed ID: 17135747
    [No Abstract]   [Full Text] [Related]  

  • 15. Therapeutic satisfaction and dissatisfaction in patients with spinal cord lesions and detrusor sphincter dyssynergia who received detrusor botulinum toxin a injection.
    Kuo HC
    Urology; 2008 Nov; 72(5):1056-60. PubMed ID: 18533231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Botulinum A toxin in the treatment of neurogenic detrusor overactivity: a consolidated field of application.
    Giannantoni A; Mearini E; Del Zingaro M; Santaniello F; Porena M
    BJU Int; 2008 Jul; 102 Suppl 1():2-6. PubMed ID: 18665971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health economics and intradetrusor injections of botulinum for the treatment of detrusor overactivity.
    Sangster P; Kalsi V
    BJU Int; 2008 Jul; 102 Suppl 1():17-9. PubMed ID: 18665974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravesical resiniferatoxin versus botulinum-A toxin injections for neurogenic detrusor overactivity: a prospective randomized study.
    Giannantoni A; Di Stasi SM; Stephen RL; Bini V; Costantini E; Porena M
    J Urol; 2004 Jul; 172(1):240-3. PubMed ID: 15201783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of botulinim toxin-A for the treatment of overactive bladder symptoms in patients with Parkinsons's disease.
    Kulaksizoglu H; Parman Y
    Parkinsonism Relat Disord; 2010 Sep; 16(8):531-4. PubMed ID: 20637678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Lantox treatment of neurogenic dysfunction of the bladder].
    Maksimov VA; Saliukov RV; Martov AG; Borisik VI; Saliukova IuR
    Urologiia; 2010; (5):53-6. PubMed ID: 21254642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.